Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 13 studies | 47% ± 24% | |
CD16-positive, CD56-dim natural killer cell, human | 11 studies | 24% ± 11% | |
mast cell | 10 studies | 34% ± 17% | |
microglial cell | 9 studies | 31% ± 9% | |
natural killer cell | 8 studies | 29% ± 12% | |
non-classical monocyte | 7 studies | 26% ± 16% | |
GABAergic neuron | 7 studies | 42% ± 18% | |
monocyte | 6 studies | 31% ± 11% | |
neuron | 5 studies | 38% ± 15% | |
interneuron | 5 studies | 42% ± 22% | |
retinal ganglion cell | 5 studies | 47% ± 19% | |
cardiac muscle cell | 5 studies | 28% ± 6% | |
dendritic cell | 5 studies | 17% ± 2% | |
granule cell | 4 studies | 40% ± 11% | |
retinal cone cell | 4 studies | 30% ± 5% | |
astrocyte | 4 studies | 27% ± 12% | |
type B pancreatic cell | 3 studies | 50% ± 32% | |
endothelial cell | 3 studies | 38% ± 14% | |
GABAergic interneuron | 3 studies | 27% ± 12% | |
OFF-bipolar cell | 3 studies | 33% ± 13% | |
retina horizontal cell | 3 studies | 32% ± 12% | |
T cell | 3 studies | 18% ± 4% | |
enteroendocrine cell | 3 studies | 41% ± 18% | |
macrophage | 3 studies | 25% ± 4% | |
type I pneumocyte | 3 studies | 21% ± 7% | |
goblet cell | 3 studies | 42% ± 26% | |
mucus secreting cell | 3 studies | 26% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
intestine | 100% | 3026.51 | 965 / 966 | 98% | 19.96 | 516 / 527 |
pancreas | 100% | 5732.58 | 328 / 328 | 98% | 28.22 | 174 / 178 |
stomach | 100% | 7816.04 | 358 / 359 | 97% | 19.29 | 278 / 286 |
esophagus | 97% | 1664.14 | 1405 / 1445 | 97% | 23.30 | 178 / 183 |
thymus | 99% | 1761.38 | 647 / 653 | 95% | 13.71 | 572 / 605 |
prostate | 93% | 2176.19 | 229 / 245 | 98% | 24.40 | 490 / 502 |
uterus | 99% | 2056.60 | 169 / 170 | 85% | 12.01 | 389 / 459 |
lung | 97% | 1859.36 | 562 / 578 | 86% | 12.92 | 993 / 1155 |
kidney | 99% | 2284.83 | 88 / 89 | 78% | 13.11 | 705 / 901 |
ovary | 97% | 1504.17 | 174 / 180 | 76% | 9.86 | 328 / 430 |
brain | 88% | 5921.52 | 2323 / 2642 | 81% | 13.21 | 572 / 705 |
breast | 75% | 1696.27 | 343 / 459 | 84% | 11.25 | 942 / 1118 |
bladder | 52% | 646.76 | 11 / 21 | 81% | 11.58 | 409 / 504 |
adrenal gland | 38% | 619.62 | 99 / 258 | 80% | 38.12 | 185 / 230 |
skin | 72% | 1543.81 | 1303 / 1809 | 32% | 3.86 | 152 / 472 |
spleen | 100% | 2251.64 | 241 / 241 | 0% | 0 | 0 / 0 |
heart | 92% | 3319.88 | 794 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 10.85 | 37 / 45 |
peripheral blood | 82% | 4263.85 | 763 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 74% | 872.06 | 992 / 1335 | 0% | 0 | 0 / 0 |
adipose | 62% | 636.70 | 752 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 24% | 1.80 | 19 / 80 |
liver | 3% | 26.41 | 7 / 226 | 20% | 2.43 | 83 / 406 |
lymph node | 0% | 0 | 0 / 0 | 10% | 0.58 | 3 / 29 |
muscle | 4% | 35.79 | 32 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0002250 | Biological process | adaptive immune response |
GO_0051056 | Biological process | regulation of small GTPase mediated signal transduction |
GO_0008361 | Biological process | regulation of cell size |
GO_0005813 | Cellular component | centrosome |
GO_0005829 | Cellular component | cytosol |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0005515 | Molecular function | protein binding |
GO_0005096 | Molecular function | GTPase activator activity |
Gene name | RAP1GAP2 |
Protein name | Rap1 GTPase-activating protein 2 (Rap1GAP2) (GTPase-activating Rap/Ran-GAP domain-like protein 4) RAP1 GTPase activating protein 2 |
Synonyms | GARNL4 KIAA1039 RAP1GA2 |
Description | FUNCTION: GTPase activator for the nuclear Ras-related regulatory protein RAP-1A (KREV-1), converting it to the putatively inactive GDP-bound state. . |
Accessions | A0A8V8TKZ8 ENST00000366401.8 [Q684P5-2] A0A8V8TL16 ENST00000697392.1 ENST00000697391.1 ENST00000540393.6 [Q684P5-3] ENST00000637138.1 A0A1B0GV05 ENST00000254695.13 [Q684P5-1] Q684P5 |